Advertisement
UK markets open in 6 hours 35 minutes

  • NIKKEI 225

    38,022.46
    -437.62 (-1.14%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.74
    -0.07 (-0.08%)
     

  • GOLD FUTURES

    2,328.80
    -9.60 (-0.41%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,661.03
    -1,689.40 (-3.17%)
     

  • CMC Crypto 200

    1,390.23
    -33.87 (-2.38%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BUZZ-Agenus Inc: Partner GSK's shingles vaccine meets goal

Reuters - UK Focus

** Biotechnology company's shares up 12 pct at $3.75 premarket

** Says shingles vaccine developed by partner GlaxoSmithKline Plc (Other OTC: GLAXF - news) met main goal in a late-stage study

** The vaccine, HZ/su, combines protein found on virus that causes shingles with a component from Agenus (NasdaqCM: AGEN - news)

** Agenus to get royalties on potential commercial sales of HZ/su

** Up to Wednesday's close, stock had risen 8 pct this year